Skip to main content

Table 3 Lifetime incidence of diabetes-related complications and depression episodes

From: The cost-effectiveness of changes to the care pathway used to identify depression and provide treatment amongst people with diabetes in England: a model-based economic evaluation

Results per 2,000,000 people Current practice (CP) Policy 1a Policy 2b Policy 3c Policy 1 — CP Policy 2 — CP Policy 3 — CP
Number of microvascular complications
 Blindness 116,237 114,360 115,070 113,287 −1,877 −1,167 −2,950
 Renal failure 68,633 66,840 66,890 66,150 −1,793 −1,743 −2,483
 Diabetic ulcer 69,320 68,803 68,633 67,920 −517 −687 −1,400
 Amputation 87,017 85,303 85,450 84,560 −1,713 −1,567 −2,457
 Total 341,207 335,306 336,043 331,917 −5,900 −5,164 −9,290
Number of macrovascular complications
 IHD 277,880 275,627 276,923 274,883 −2,253 −957 −2,997
 MI 377,417 374,227 374,190 373,437 −3,190 −3,227 −3,980
 Stroke 274,880 273,010 272,980 271,650 −1,870 −1,900 −3,230
 CHF 221,130 219,640 219,250 218,587 −1,490 −1,880 −2,543
 Total 1,151,307 1,142,504 1,143,343 1,138,557 −8,803 −7,964 −12,750
Number depression episodes (1,000)
 Total number 15,517 15,598 15,563 15,605 80 46 88
 Identified 7,937 7,983 13,547 13,588 46 5,610 5,650
 Unidentified 7,580 7,615 2,016 2,018 35 −5,564 −5,562
  1. CP Current practice, IHD Ischaemic heart disease, MI Myocardial infarction, CHF Congestive heart failure. aPolicy 1 = collaborative care; bPolicy 2 = opportunistic screening; cPolicy 3 = both collaborative care and opportunistic screening